|
N (%)
|
circDENND4C level
|
P value
|
---|
High (%)
|
Low (%)
|
---|
Age(years)
|
P > 0.05
|
≥ 55
|
24 (55.8)
|
13 (54.2)
|
11 (45.8)
| |
< 55
|
19 (44.2)
|
10 (52.6)
|
9 (47.4)
| |
Menopause
|
P > 0.05
|
No
|
26 (60.5)
|
14 (53.8)
|
12 (46.2)
| |
Yes
|
17 (39.5)
|
9 (52.9)
|
8 (47.1)
| |
TNM stage
|
P < 0.05
|
I-II
|
23 (53.5)
|
8 (34.8)
|
15 (65.2)
| |
III-IV
|
20 (46.5)
|
15 (75.0)
|
5 (25.0)
| |
Lymph node metastasis
|
P < 0.05
|
No
|
22 (51.2)
|
8 (36.4)
|
14 (63.6)
| |
Yes
|
21 (48.8)
|
15 (71.4)
|
6 (28.6)
| |
Tumor size
|
P < 0.05
|
≥ 2 cm
|
25 (58.1)
|
17 (68.0)
|
8 (32.0)
| |
< 2 cm
|
18 (41.9)
|
6 (33.3)
|
12 (66.7)
| |
Subtype
| | | |
P > 0.05
|
TNBC
|
19 (44.2)
|
10 (52.6)
|
9 (47.4)
| |
HER2
|
5 (11.6)
|
3 (60.0)
|
2 (40.0)
| |
Luminal A
|
8 (18.6)
|
4 (50)
|
4 (50)
| |
Luminal B
|
11 (25.6)
|
6 (54.5)
|
5 (45.5)
| |
- Abbreviations: TNM tumor node metastasis, TNBC triple negative breast cancer, HER2 human epidermal growth factor receptor 2